$20.0M
OMRON Ventures joins existing backers including abrdn, Environmental Technologies Fund, and Granpool Innovative Investments in backing the TechBio platform.
a
abrdn
Venture Capitalabrdn is an investment company that has become the largest external shareholder in Archax through its strategic backing.
Portfolio
3
companies
By category
- AI/ML£37.5M
- FinTech£35.0M
- BioTech£33.8M
By location
- London£72.5M
- Cambridge£33.8M
Portfolio companies
A
Archax
Archax operates a regulated digital asset exchange, brokerage and custodian for institutional investors.
Eagle Genomics
Eagle Genomics develops bioinformatics software for pharmaceutical and life science research.
SA
Signal AI
Signal AI provides an augmented intelligence platform that helps corporate leaders monitor news and regulatory data.
Team
SB
Stephen Bird
CEO
Alistair Watson
Head of Strategy Innovation – Private Equity
Alistair is partner and deputy head of private equity for global private market solutions at Patria Investments. He previously held senior private equity roles at abrdn and served as a committee member at Social and Sustainable Capital.
LinkedInRB
Russel Barlow
Global Head of Alternatives
Recent investments
£25.0M
The funding round was led by abrdn with participation from international backers.
"We are extremely pleased to have been able to complete a round of this size during the turbulent crypto and traditional financial market conditions of the last few months. It is also fantastic to have such credible and strategic partner investors involved in the raise too – led by abrdn. We look forward to the next phase of the Archax journey as we scale up for launch and beyond with these partnerships in place."
£17.4M
The funding round was led by abrdn and will support platform development and international expansion.
"We are the pre-eminent platform business using next-generation graph technology and network science to drive the Bioeconomy. We are seeking to support our enterprise customers as they strive to achieve more sustainable and impact-orientated innovation outcomes. The current scale-up funding will enable us to accelerate the Bioeconomy through the digital reinvention of science."
£10.0M
abrdn takes a strategic stake in Archax to back its regulated digital securities exchange.
"Blockchain technologies are inevitably going to form a big part of the future of financial markets. There is the potential to offer greater transparency, greater speed and less trading friction by using these nascent digital technologies."
$50.0M
Highland Europe led the round with participation from abrdn, Redline Capital, MMC, Hearst and GMG Ventures.
"Our vision at Signal AI is to transform business decision making through augmented intelligence. We are thrilled to have Highland Europe and abrdn join us in this latest round and appreciate the continued belief and support of our existing investors. The investment will allow us to continue to attract the best in class ML and AI product engineering talent, to scale our AIQ platform, grow our international hubs and advance the use of our decision augmentation solution with some of the world’s biggest companies."
